Lucy E Rasmussen

Title: The Innovative Contributions of Lucy E. Rasmussen

Introduction

Lucy E. Rasmussen is a prominent inventor based in Menlo Park, CA (US). She has made significant contributions to the field of medical research, particularly in the study of human cytomegalovirus (CMV). With a total of 3 patents to her name, her work has implications for vaccine development and antibody detection.

Latest Patents

Rasmussen's latest patents focus on a purified human cytomegalovirus protein. This protein has a molecular weight of approximately 86,000 daltons as determined by SDS-PAGE. It exhibits in vivo immunizing activity and is associated with a murine monoclonal antibody that binds specifically to the protein. This antibody demonstrates complement-independent human CMV neutralizing activity. The antibody is useful for isolating the protein through affinity chromatography. Furthermore, the protein serves as a valuable tool for detecting CMV neutralizing antibodies in sera and has potential applications as a vaccine.

Career Highlights

Lucy E. Rasmussen is affiliated with Leland Stanford Junior University, where she conducts her research. Her work has garnered attention for its innovative approach to tackling challenges associated with CMV.

Collaborations

Rasmussen collaborates with Thomas C. Merigan, a fellow researcher in the field. Their partnership enhances the research efforts aimed at understanding and combating CMV.

Conclusion

Lucy E. Rasmussen's contributions to the field of medical research, particularly through her patents related to human cytomegalovirus, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also has the potential to improve public health outcomes.